2021
DOI: 10.3390/biology10121312
|View full text |Cite
|
Sign up to set email alerts
|

A Blood–Bone–Tooth Model for Age Prediction in Forensic Contexts

Abstract: The development of age prediction models (APMs) focusing on DNA methylation (DNAm) levels has revolutionized the forensic age estimation field. Meanwhile, the predictive ability of multi-tissue models with similar high accuracy needs to be explored. This study aimed to build multi-tissue APMs combining blood, bones and tooth samples, herein named blood–bone–tooth-APM (BBT-APM), using two different methodologies. A total of 185 and 168 bisulfite-converted DNA samples previously addressed by Sanger sequencing an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 39 publications
(86 reference statements)
1
9
0
Order By: Relevance
“…In 2012, we reported the strong correlation between DNAm of cg16867657 within ELOVL2 and chronological age in whole blood [ 35 ], and since then this region has been confirmed as robustly associated with aging in several tissues [ 36 , 37 ]. The assessment of ELOVL2 DNAm is largely employed in targeted epigenetic biomarkers developed for forensic applications [ 38 , 39 , 40 , 41 ]. Although we previously reported that hypermethylation of this genomic region in blood is associated with the prospective development of breast cancer [ 42 ], ELOVL2 DNAm seems to depend mainly on chronological age, and Spólnicka et al reported that no changes in ELOVL2 DNAm occur in Alzheimer’s and Graves’ diseases [ 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…In 2012, we reported the strong correlation between DNAm of cg16867657 within ELOVL2 and chronological age in whole blood [ 35 ], and since then this region has been confirmed as robustly associated with aging in several tissues [ 36 , 37 ]. The assessment of ELOVL2 DNAm is largely employed in targeted epigenetic biomarkers developed for forensic applications [ 38 , 39 , 40 , 41 ]. Although we previously reported that hypermethylation of this genomic region in blood is associated with the prospective development of breast cancer [ 42 ], ELOVL2 DNAm seems to depend mainly on chronological age, and Spólnicka et al reported that no changes in ELOVL2 DNAm occur in Alzheimer’s and Graves’ diseases [ 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…An age prediction accuracy rate of 80% was established when we applied a ± 1 SEE value as the prediction interval. Comparable studies generally report MAE values ranging from 3 to 6.5 years [13, 47–49]. For instance, Onofri et al.…”
Section: Discussionmentioning
confidence: 99%
“…Jung et al showed that the prediction formulas differ slightly for blood, saliva, and buccal swabs, and presented a suitable formula for tissue samples tested [10]. Dias et al also reported a universal prediction formula using blood, bone, and tooth samples [24]. However, age prediction formulas using different amounts of DNA have not been reported, and the accuracy of using small amounts of DNA has not been clarified.…”
Section: Discussionmentioning
confidence: 99%